Account
Insider Insights
12.06.2024
Scotland leads the UK in approving Mounjaro for ob...

Scottish Medicines Consortium approves the use of obesity treatment under the NHS in UK first, whils...

Read more
Insider Insights
21.05.2024
The Bundesrat rejected confidential rebates propos...

The German government’s proposal to keep negotiated confidential rebates was rejected by the feder...

Read more
Articles
27.03.2024
How will recent safety signals impact patient acce...

Safety signals have sparked vital discussions on patient access to ATMPs, marking a pivotal moment i...

Read more
Insider Insights
22.02.2024
Nordic Pharmaceutical Forum develops new website t...

New website provides regular updates on NLF's work, addresses challenges, and showcases collaboratio...

Read more
News
13.02.2024
World EPA Congress 2024

The World Evidence, Pricing, and Access (EPA) Congress stands as Europe’s premier event in mar...

Read more
Insider Insights
06.02.2024
Confidential rebates are raising concerns in Germa...

Proposed changes in Germany's pharma strategy suggest replacing publicly listed AMNOG rebates with c...

Read more
Insider Insights
30.01.2024
New MHRA procedure can accelerate patient access t...

The Medicines and Healthcare products Regulatory Agency (MHRA) in the UK has implemented the Interna...

Read more
Articles
24.01.2024
What are the 5 Pricing & Market Access trends...

Our experts provide an overview of the five key trends that could shape the pricing and market acces...

Read more
Articles
13.12.2023
Reflecting on the Pricing & Market Access tre...

Back in January this year, we summarised the key trends our market access experts believed would dom...

Read more
Insider Insights
06.12.2023
New rebate percentages in the Statutory Scheme are...

The statutory scheme has been updated with new percentages for 2024-2026, and has received backlash ...

Read more

Stay in the know, subscribe to our newsletter

Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.